Lubiprostone
Brand name: Lubiprostone
Rank #415 of 500 drugs by total cost
$21.1M
Total Cost
86,987
Total Claims
$21.1M
Total Cost
4,193
Prescribers
$243
Cost per Claim
4,627
Beneficiaries
108,269
30-Day Fills
$5,039
Avg Cost/Provider
21
Avg Claims/Provider
About Lubiprostone
Lubiprostone (sold as Lubiprostone) was prescribed 86,987 times by 4,193 Medicare Part D providers in 2023, costing the program $21.1M. At $243 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 412 | Desvenlafaxine Succinate (Desvenlafaxine Succinate Er) | $21.3M | 257,580 |
| 413 | Sotorasib (Lumakras) | $21.3M | 1,188 |
| 414 | Ibuprofen (Ibuprofen) | $21.2M | 2,537,634 |
| 415 | Lubiprostone (Lubiprostone) | $21.1M | 86,987 |
| 416 | Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters) | $21.0M | 239,899 |
| 417 | Methenamine Hippurate (Methenamine Hippurate) | $21.0M | 246,988 |
| 418 | Daratumumab-Hyaluronidase-Fihj (Darzalex Faspro) | $21.0M | 1,444 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology